#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hypereosinophilic syndrome Non-small cell lung cancer recurrent Thymic carcinoma Hypochromic anaemia Choroid melanoma Acute myeloid leukaemia refractory Glomerulonephritis Glioblastoma multiforme Non-Hodgkin's lymphoma unspecified histology indolent Progressive supranuclear palsy Anal fistula Thermal burn Glomerulonephritis rapidly progressive Cold type haemolytic anaemia Shprintzen-Goldberg syndrome More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Trials in Disease Cytokine release syndrome – Trials in Disease Splenic marginal zone lymphoma – Diagnostics Alveolar rhabdomyosarcoma – Treatment Primary mediastinal large B-cell lymphoma – Diagnostics Chondrosarcoma metastatic – Diagnostics Alveolar rhabdomyosarcoma – Trials in Disease Idiopathic pulmonary fibrosis – Trials in Disease Hereditary hypophosphataemic rickets – Diagnostics Osteosarcoma recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    1,3-BUTYLENE GLYCOL Lasn01 CIRTUVIVINT Magnesium Sulfate Heptahydrate Arginine Hydrochloride IMA401 SOVATELTIDE 204-NETU Lurasidone Pemetrexed Disodium Mometasone Furoate Ph. Eur. Davutamig Axatilimab Gallium (68Ga) Chloride Dabrafenib Mesylate Etifoxine Hydrochloride Neostigmine Methylsulfate Alks 2680 Sulfasalazine Gliquidone More therapies…

    Learn about Your Condition

    Migraine Cervix carcinoma stage I Familial mediterranean fever Post procedural swelling Myocarditis Left ventricular failure Osteonecrosis of jaw Advanced systemic mastocytosis Pleural mesothelioma malignant Thrombosis Metastases to biliary tract Immunosuppression Childhood asthma Metastases to meninges Muscle strain More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Weekly Oral GS-1720 and GS-4182 for People with HIV-1 Who Are Virologically Suppressed

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • GS-1720
    • Gs-4182
    • Bictegravir
    France Germany Italy Poland Spain Sweden

  • Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Alpelisib
    Croatia

  • Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study on Propranolol for Preventing PTSD in Women After Sexual Violence

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Propranolol
    France

  • Study on Eplerenone for Heart Health in Kidney Transplant Patients Using Cyclosporine or Tacrolimus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    France

  • Study on Sirolimus and Prednisolone for Treating Superficial Arteriovenous Malformations in Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital arterial malformation
    Investigated Drugs:
    • Prednisolone Metasulfobenzoate Sodium
    • Sirolimus
    France
Previous Page
1 … 817 818 819 820 821 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!